FDA Issues Final Guidance on GMPs for APIs

International Pharmaceutical Regulatory Monitor
A A
The FDA released final guidance on its Q7 guidelines on good manufacturing practices for active pharmaceutical ingredients, using a question and answer format to clarify the document developed through the International Conference on Harmonization.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor